To assess the direct interaction of ONCOFID-P and ONCOFID-S with CD44 expressing target cells, bioconjugates were labeled with the BODIPY fluorophore, incubated with tumor lines and analyzed cytofluorimetrically at different time points. This evidence concerns the gene CD44 and neoplasm.